Why the study?
Does mechanical versus bioprosthetic valve replacement affect the incidence of MAPE in middle-aged patients?
Does mechanical versus bioprosthetic valve replacement affect the incidence of MAPE in middle-aged patients?
Current data do not support lowering the usual age cutoff for tissue valve implantation below 65 years.
Answers are grounded in this paper and cite their sources.
Current data do not support lowering the bioprosthetic valve age cutoff below 65; leaves open differential MAPE risk by prosthesis type.
In middle-aged patients, MAPE may occur more often in patients with bioprosthetic valves, but definitive conclusions necessitate the accumulation of additional follow-up. At present, these data do not support lowering the usual cutoff for implantation of a tissue valve below the age of 65.
No takes yet. Share an insight, caveat, or question.
Kulik et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: